BDMD (Baird Medical Investment Holdings) Net Income From Continuing Operations : $10.66 Mil (TTM As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Baird Medical Investment Holdings's net income from continuing operations for the six months ended in Dec. 2023 was $10.66 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was $10.66 Mil.

Baird Medical Investment Holdings Net Income From Continuing Operations Historical Data

The historical data trend for Baird Medical Investment Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Net Income From Continuing Operations Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Net Income From Continuing Operations

10.18

12.78

10.66

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Dec23
Net Income From Continuing Operations	10.18	12.78	10.66

Baird Medical Investment Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 was $10.66 Mil.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Baird Medical Investment Holdings Headlines

From GuruFocus

Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference

By PRNewswire • 10-08-2024